CLINICAL_TRIALS
trial_result
· 2023-02-27
Clinical Trial Update: Agrylin Drug Use-Result Survey
Summary
Clinical trial update for Agrylin (anagrelide) showing results from a completed study on essential thrombocythemia; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Essential Thrombocythemia (ET) | Status: COMPLETED | Results posted: 2023-02-27